Manus AI : China’s Autonomous Agent Shakes Up the AI Race

Reading Time : 3 minutesManus, a new AI agent from China, promises true autonomy, handling complex tasks with minimal input. Its rapid rise has sparked comparisons to DeepSeek, raising questions about China’s AI advancements. While powerful, Manus has drawbacks like slow performance and occasional errors. As competition intensifies, the battle for AI dominance is far from over.

BYD Offers Smart Driving Tech for Free, Challenging Tesla

Reading Time : 2 minutesBYD’s bold move to offer its “God’s Eye” smart driving system for free shakes up the EV market, challenging Tesla’s $8,800 tech. As competition intensifies, the future of affordable autonomous driving looks more dynamic than ever.

Google Launches AI Co-Scientist to Transform Research

Reading Time : 2 minutesGoogle’s AI co-scientist, part of the Gemini 2.0 platform, promises to transform scientific research by generating hypotheses and expediting discoveries. Early results show significant potential, but ethical concerns and limitations must be addressed through a Trusted Tester Program aimed at responsible exploration.

Musk’s Bold Move : $97B Bid for OpenAI Control

Reading Time : 2 minutesTech mogul Elon Musk, leading a consortium, has made a stunning $97.4 billion bid to seize control of OpenAI, the AI powerhouse behind ChatGPT. This move follows escalating legal battles and accusations that OpenAI has strayed from its original mission.

DeepSeek’s Success Sparks Debate on U.S. Tech Export Controls

Reading Time : 2 minutes
The emergence of DeepSeek’s AI assistant has sparked significant discussions around U.S. tech export controls and their implications for global competition. As the app gains traction, it challenges existing policies and raises questions about the future of AI regulation and innovation.

AI Drugs on the Horizon

Reading Time : 2 minutes AI is revolutionizing drug discovery by predicting how new compounds interact with biological targets, potentially reducing development time and costs. However, challenges like regulatory adaptation, data privacy, and real-world efficacy must be addressed for widespread success.